US Solar Fund (USF) Competitors GBX 0.38 -0.01 (-3.31%) As of 08/22/2025 04:28 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesBuy This Stock USF vs. RTW, ATR, OAP3, POLR, TAM, GHE, TPOU, GRID, BHGG, and JCHShould you be buying US Solar Fund stock or one of its competitors? The main competitors of US Solar Fund include RTW Biotech Opportunities (RTW), Schroder Asian Total Return Inv. (ATR), Octopus Apollo VCT (OAP3), Polar Capital (POLR), Tatton Asset Management (TAM), Gresham House (GHE), Third Point Investors (TPOU), Gresham House Energy Storage (GRID), BH Global (BHGG), and JPMorgan Claverhouse (JCH). These companies are all part of the "asset management" industry. US Solar Fund vs. Its Competitors RTW Biotech Opportunities Schroder Asian Total Return Inv. Octopus Apollo VCT Polar Capital Tatton Asset Management Gresham House Third Point Investors Gresham House Energy Storage BH Global JPMorgan Claverhouse RTW Biotech Opportunities (LON:RTW) and US Solar Fund (LON:USF) are both small-cap financial services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, media sentiment and dividends. Is RTW or USF more profitable? RTW Biotech Opportunities has a net margin of 664.38% compared to US Solar Fund's net margin of 107.10%. RTW Biotech Opportunities' return on equity of 25.18% beat US Solar Fund's return on equity.Company Net Margins Return on Equity Return on Assets RTW Biotech Opportunities664.38% 25.18% -0.47% US Solar Fund 107.10%-14.89%N/A Do insiders and institutionals believe in RTW or USF? 3.9% of RTW Biotech Opportunities shares are owned by institutional investors. Comparatively, 91.4% of US Solar Fund shares are owned by institutional investors. 16.2% of RTW Biotech Opportunities shares are owned by insiders. Comparatively, 0.1% of US Solar Fund shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has better earnings and valuation, RTW or USF? RTW Biotech Opportunities has higher revenue and earnings than US Solar Fund. US Solar Fund is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRTW Biotech Opportunities£2.12B0.22£14.09B£0.423.34US Solar Fund-£3.73B-0.03-£3.99B-£0.13-2.93 Does the media favor RTW or USF? In the previous week, RTW Biotech Opportunities had 1 more articles in the media than US Solar Fund. MarketBeat recorded 1 mentions for RTW Biotech Opportunities and 0 mentions for US Solar Fund. US Solar Fund's average media sentiment score of 1.11 beat RTW Biotech Opportunities' score of 1.08 indicating that US Solar Fund is being referred to more favorably in the news media. Company Overall Sentiment RTW Biotech Opportunities Positive US Solar Fund Positive SummaryRTW Biotech Opportunities beats US Solar Fund on 9 of the 12 factors compared between the two stocks. Get US Solar Fund News Delivered to You Automatically Sign up to receive the latest news and ratings for USF and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart USF vs. The Competition Export to ExcelMetricUS Solar FundAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£116.98M£1.31B£6.49B£3.22BDividend Yield8.26%4.39%4.17%5.04%P/E Ratio-2.9322.7214.41164.70Price / Sales-0.032,489.741,803.70310,111.42Price / CashN/A60.6249.0727.93Price / Book0.001.423.505.91Net Income-£3.99B£265.04M£1.23B£5.89B7 Day Performance-0.52%0.57%0.88%49.51%1 Month Performance-5.94%0.96%2.15%56.91%1 Year Performance-18.28%6.88%24.63%140.38% US Solar Fund Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)USFUS Solar FundN/AGBX 0.38-3.3%N/A-18.3%£116.98M-£3.73B-2.93N/AGap UpHigh Trading VolumeRTWRTW Biotech OpportunitiesN/AGBX 1.40+1.1%N/AN/A£470.28M£2.12B3.344,971News CoverageGap UpATRSchroder Asian Total Return Inv.N/AGBX 498-0.4%N/A+7.6%£465.75M£75.15M6.9713,500News CoverageOAP3Octopus Apollo VCTN/AGBX 48+3.2%N/AN/A£461.71M£2.55M-80.14N/AGap DownPOLRPolar Capital2.4166 of 5 starsGBX 477.50-1.5%GBX 555+16.2%-9.3%£456.41M£208.88M11.13135Gap UpTAMTatton Asset ManagementN/AGBX 750+1.6%N/A+0.8%£453.28M£37.17M33.82103Positive NewsHigh Trading VolumeGHEGresham HouseN/AN/AN/AN/A£451.55M£86.03M3,055.56216TPOUThird Point InvestorsN/AGBX 25.30-1.6%N/A+16.1%£449.83M£8.39B6.79N/AGRIDGresham House Energy Storage2.5772 of 5 starsGBX 79-0.9%N/A+30.3%£448.49M-£186.53M-2.28N/ANews CoverageAnalyst ForecastBHGGBH GlobalN/AN/AN/AN/A£444.68M£837K5.12N/AJCHJPMorgan ClaverhouseN/AGBX 798-0.5%N/A+12.3%£443.61M£62.40M7.68N/A Related Companies and Tools Related Companies RTW Alternatives ATR Alternatives OAP3 Alternatives POLR Alternatives TAM Alternatives GHE Alternatives TPOU Alternatives GRID Alternatives BHGG Alternatives JCH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:USF) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding US Solar Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share US Solar Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access